FORM DEF 14A

Company

IGC Pharma, Inc.

Filed

September 15, 2021

Period of Report

October 15, 2021

Accession Number

0001185185-21-001301

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →